Who invested in SiteOne Therapeutics?
SiteOne Therapeutics's investors include Next Frontier Capital, Sears Capital Management, BioBrit, Amgen and OrbiMed, and 5 more on record.
United States · Series C startup
5 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$119Mraised across 5 rounds since 2014, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
From a historical funding recordSEC filing: $1.3M sold, first sale Jul 2015
No investor was named in the report.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
SiteOne Therapeutics's investors include Next Frontier Capital, Sears Capital Management, BioBrit, Amgen and OrbiMed, and 5 more on record.
SiteOne Therapeutics has raised $119M across 5 rounds since 2014.
SiteOne Therapeutics's most recent round was a Series C of $100M in Dec 2024.
Its most recent round, $100M in Dec 2024, is also its largest on record.
SiteOne Therapeutics's first round on record, in Sept 2014, was backed by Bay Capital, Sears Capital Management and BioBrit.
SiteOne Therapeutics's latest named round is a Series C, in Dec 2024.
SiteOne Therapeutics is based in the United States.
Amgen led the Series B in 2017.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.